Highlights NEOVACS

Equities

Market Closed - Euronext Paris Other stock markets 16:35:11 07/06/2024 BST			5-day change	1st Jan Change
0.098 ^EUR	-12.66%		-31.94%	-95.10%

06-04	Néovavs: raises 200,000 euros through the issue of OCEANE-BSA bonds	CF
05-29	Neovacs: mRNA approach validated in preclinical trial	CF

Néovavs: raises 200,000 euros through the issue of OCEANE-BSA bonds	06-04	CF
Neovacs: mRNA approach validated in preclinical trial	05-29	CF
Neovacs: collaboration contract with INSERM team	05-27	CF
Neovacs S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Reverse Split: 1 of 10000	02-01	FA

No results for this search